SPRY4 and melanoma: In this study, we evaluated the expression levels of SPRY4‐IT1 in the plasma of patients with melanoma and healthy controls by qRT‐PCR for the first time, and explored clinical significance of SPRY4‐IT1 in melanoma patients.